[go: up one dir, main page]

AR028331A1 - Formula para bebes que contiene acidos grasos poli-insaturados de cadena larga y sus usos - Google Patents

Formula para bebes que contiene acidos grasos poli-insaturados de cadena larga y sus usos

Info

Publication number
AR028331A1
AR028331A1 ARP010101740A ARP010101740A AR028331A1 AR 028331 A1 AR028331 A1 AR 028331A1 AR P010101740 A ARP010101740 A AR P010101740A AR P010101740 A ARP010101740 A AR P010101740A AR 028331 A1 AR028331 A1 AR 028331A1
Authority
AR
Argentina
Prior art keywords
insaturated
formula
fatty acids
long chain
chain fatty
Prior art date
Application number
ARP010101740A
Other languages
English (en)
Original Assignee
Abbott Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22727498&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AR028331(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Abbott Lab filed Critical Abbott Lab
Publication of AR028331A1 publication Critical patent/AR028331A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A23L33/12—Fatty acids or derivatives thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
    • A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nutrition Science (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Mycology (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pediatric Medicine (AREA)
  • Obesity (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Ophthalmology & Optometry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Dairy Products (AREA)
ARP010101740A 2000-04-13 2001-04-11 Formula para bebes que contiene acidos grasos poli-insaturados de cadena larga y sus usos AR028331A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US19697000P 2000-04-13 2000-04-13

Publications (1)

Publication Number Publication Date
AR028331A1 true AR028331A1 (es) 2003-05-07

Family

ID=22727498

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP010101740A AR028331A1 (es) 2000-04-13 2001-04-11 Formula para bebes que contiene acidos grasos poli-insaturados de cadena larga y sus usos

Country Status (15)

Country Link
US (3) US6495599B2 (es)
EP (1) EP1272058B1 (es)
JP (2) JP2004518609A (es)
KR (1) KR100793048B1 (es)
CN (1) CN1436048A (es)
AR (1) AR028331A1 (es)
AU (1) AU2001255337A1 (es)
BR (1) BR0107069A (es)
CA (1) CA2405822C (es)
DK (1) DK1272058T3 (es)
ES (1) ES2544853T3 (es)
IL (2) IL151970A0 (es)
MX (1) MXPA02010085A (es)
SA (1) SA02220638B1 (es)
WO (1) WO2001078530A2 (es)

Families Citing this family (129)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19836339B4 (de) 1998-08-11 2011-12-22 N.V. Nutricia Kohlenhydratmischung
US6495599B2 (en) * 2000-04-13 2002-12-17 Abbott Laboratories Infant formulas containing long-chain polyunsaturated fatty acids and uses therof
EP1178103A1 (en) * 2000-08-02 2002-02-06 Dsm N.V. Purifying crude pufa oils
US6818392B2 (en) 2000-12-06 2004-11-16 Abbott Laboratories Monoclonal antibodies to human immunodeficiency virus and uses thereof
US6648864B2 (en) 2000-12-12 2003-11-18 The Procter & Gamble Company Array of disposable absorbent article configurations and merchandise display system for identifying disposable absorbent article configurations for wearers
US20100056762A1 (en) 2001-05-11 2010-03-04 Old Lloyd J Specific binding proteins and uses thereof
EP1392359B2 (en) 2001-05-11 2013-03-13 Ludwig Institute for Cancer Research Ltd. Specific binding proteins and uses thereof
US20110033542A1 (en) 2009-08-07 2011-02-10 Monosol Rx, Llc Sublingual and buccal film compositions
US7357891B2 (en) 2001-10-12 2008-04-15 Monosol Rx, Llc Process for making an ingestible film
US8900498B2 (en) 2001-10-12 2014-12-02 Monosol Rx, Llc Process for manufacturing a resulting multi-layer pharmaceutical film
US11207805B2 (en) 2001-10-12 2021-12-28 Aquestive Therapeutics, Inc. Process for manufacturing a resulting pharmaceutical film
US8603514B2 (en) 2002-04-11 2013-12-10 Monosol Rx, Llc Uniform films for rapid dissolve dosage form incorporating taste-masking compositions
US8900497B2 (en) 2001-10-12 2014-12-02 Monosol Rx, Llc Process for making a film having a substantially uniform distribution of components
US20070281003A1 (en) 2001-10-12 2007-12-06 Fuisz Richard C Polymer-Based Films and Drug Delivery Systems Made Therefrom
US8765167B2 (en) 2001-10-12 2014-07-01 Monosol Rx, Llc Uniform films for rapid-dissolve dosage form incorporating anti-tacking compositions
US10285910B2 (en) 2001-10-12 2019-05-14 Aquestive Therapeutics, Inc. Sublingual and buccal film compositions
US20190328679A1 (en) 2001-10-12 2019-10-31 Aquestive Therapeutics, Inc. Uniform films for rapid-dissolve dosage form incorporating anti-tacking compositions
US20040048926A1 (en) * 2002-03-15 2004-03-11 Hoffman Dennis Robert Use of docosahexaenoic acid and arachidonic acid to enhance the visual development of term infants breast-fed up to the age of six months
FR2839887A1 (fr) 2002-05-22 2003-11-28 Synergia Nouvelles compositions nutraceutiques et pharmaceutiques et leurs utilisations
WO2004002232A1 (en) * 2002-06-28 2004-01-08 Theuer Richard C Fat compositions for infant formula and methods therefor
TW200412942A (en) * 2002-08-06 2004-08-01 Abbott Lab Appetite control method
DE60325748D1 (de) * 2002-10-10 2009-02-26 Wyeth Corp Nukleotidhaltige fertig-babynahrung
US20050175759A1 (en) * 2004-02-09 2005-08-11 Atul Singhal Newborn infant formulas and feeding methods
US8815279B2 (en) * 2003-02-10 2014-08-26 University College London Baby feeding formula and system
US6753350B1 (en) * 2003-03-24 2004-06-22 Bristol-Myers Squibb Company Method to reduce the incidence of intraventricular hemorrhage in preterm infants
US7951410B2 (en) 2003-04-14 2011-05-31 Mead Johnson Nutrition Company Enteral compositions containing caseinoglycomacropeptide having an enhanced concentration of sialic acid
US20040214791A1 (en) * 2003-04-25 2004-10-28 Nancy Auestad High lactose infant nutrition formula
PT1638414E (pt) * 2003-06-23 2009-07-13 Nestec Sa Fórmula para lactentes ou fórmula de transição
PL1638415T3 (pl) * 2003-06-23 2011-05-31 Nestec Sa Preparat dla niemowląt lub preparat pochodny
KR20060030860A (ko) * 2003-06-24 2006-04-11 유니버시티 오브 캔사스 메디컬 센터 유아 조제유
BRPI0412368A (pt) * 2003-07-09 2006-09-05 J Oil Mills Inc composição de gordura ou óleo
EP1716766A1 (en) * 2003-07-21 2006-11-02 Unilever N.V. Aiding of cognitive function
CA2436650A1 (en) * 2003-08-06 2005-02-06 Naturia Inc. Conjugated linolenic acid (clnatm) compositions: synthesis, purification and uses
IL158555A0 (en) * 2003-10-22 2004-05-12 Enzymotec Ltd Human breast milk lipid mimetic as dietary supplement
US20050249823A1 (en) * 2003-11-04 2005-11-10 Murphy Tanya K Methods for the prevention or amelioration of neuropsychiatric and related diseases
WO2005063050A1 (en) * 2003-12-19 2005-07-14 Abbott Laboratories Method of increasing lean body mass and reducing body fat mass in infants
SE0303513D0 (sv) * 2003-12-19 2003-12-19 Pronova Biocare As Use of a fatty acid composition comprising at least one of epa and dha or any combinations thereof
EP1597978A1 (en) 2004-05-17 2005-11-23 Nutricia N.V. Synergism of GOS and polyfructose
US8252769B2 (en) * 2004-06-22 2012-08-28 N. V. Nutricia Intestinal barrier integrity
CN101693103B (zh) * 2004-06-22 2013-04-10 努特里希亚公司 肠屏障完整性的改进
ES2253089B1 (es) * 2004-07-16 2007-08-16 Berthol Victor Laboratorios Ordesa, S.L. Complemento nutraceutico para la preparacion de leches infantiles.
JP5160229B2 (ja) 2004-09-30 2013-03-13 モノソル・アールエックス・エルエルシー 均一の成分を有する多層フィルム
EP1656839A1 (en) * 2004-11-11 2006-05-17 N.V. Nutricia Nutrition containing lipid blend
WO2006072084A2 (en) * 2004-12-30 2006-07-06 Hill's Pet Nutrition, Inc. Methods for enhancing the quality of life of a growing animal
CA2537452C (en) 2005-03-09 2013-12-24 Abbott Laboratories Concentrated human milk fortifier liquid
US20060233915A1 (en) * 2005-04-15 2006-10-19 Bristol-Myers Squibb Company Liquid nutritional product to supplement human milk
AU2006251562B2 (en) 2005-05-23 2012-03-22 Massachusetts Institute Of Technology Compositions containing PUFA and methods of use thereof
US9179702B2 (en) * 2005-07-13 2015-11-10 Abbott Laboratories Liquid nutritional compositions containing unsaturated fatty acids
EP1919293A4 (en) * 2005-07-20 2010-11-17 James S Brophy MODIFICATION OF PARTICLE MORPHOLOGY TO ENHANCE THE FUNCTIONALITY OF A PRODUCT
CA2624921C (en) * 2005-10-05 2012-07-10 Nestec S.A. Nutritional formulation for promoting catch-up growth
EP1776877A1 (en) 2005-10-21 2007-04-25 N.V. Nutricia Method for stimulating the intestinal flora
US20070166354A1 (en) * 2005-10-26 2007-07-19 Bridget Barrett-Reis Method of reducing the risk of retinopathy of prematurity in preterm infants
US7829126B2 (en) 2005-10-26 2010-11-09 Abbott Laboratories Infant formulas containing docosahexaenoic acid and lutein
US20070166411A1 (en) * 2005-12-16 2007-07-19 Bristol-Myers Squibb Company Nutritional supplement containing long-chain polyunsaturated fatty acids
WO2008054192A1 (en) * 2006-11-02 2008-05-08 N.V. Nutricia Use of nutritional compositions for preventing disorders
ATE509624T1 (de) 2005-12-23 2011-06-15 Nutricia Nv Zusammensetzung enthaltend mehrfach ungesättigte fettsäuren, proteine, mangan und/oder molybden und nukleotide/nukleoside, zur behandlung von demenz
RU2432090C2 (ru) * 2006-01-31 2011-10-27 Нестек С.А. Питательная композиция
US7770729B2 (en) * 2006-05-01 2010-08-10 The Procter & Gamble Company Array of multi-staged cleaning wipes
US9185922B2 (en) 2006-06-02 2015-11-17 University Of Guelph Dairy product
US20070280998A1 (en) * 2006-06-02 2007-12-06 Larry Milligan Dairy product
US20110183050A1 (en) * 2006-07-20 2011-07-28 Brophy James S Modification of particle morphology to improve product functionality
CA2684929C (en) * 2007-05-18 2015-05-26 Mead Johnson Nutrition Company Acidified liquid human milk supplement
US7959621B2 (en) 2007-07-24 2011-06-14 The Procter & Gamble Company Array of disposable absorbent articles having a sequence of graphics corresponding to a wearer's stages of development
WO2009099886A1 (en) * 2008-01-31 2009-08-13 Monsanto Technology Llc Methods of improving dha deposition and related function and/or development
CN101584364B (zh) * 2008-05-22 2012-11-21 内蒙古伊利实业集团股份有限公司 含有益智因子组合的液态乳制品及其制备方法
MX2010013844A (es) 2008-06-19 2011-01-14 Unilever Nv Emulsiones comestibles que contienen grasas con hierro y zinc.
AR073485A1 (es) 2008-09-02 2010-11-10 Nutricia Nv Composiciones nutricionales con globulos lipidicos de gran tamano
WO2010068086A1 (en) 2008-12-11 2010-06-17 N.V. Nutricia Nutritional compositions with large lipid globule size
CN102271534B (zh) * 2009-01-19 2014-07-09 雀巢产品技术援助有限公司 婴儿用营养组合物
WO2010110649A1 (en) * 2009-03-24 2010-09-30 N.V. Nutricia Stage 1 and stage 2 infant formula
AU2009201540B2 (en) * 2009-04-20 2015-07-09 South Australian Health And Medical Research Institute Limited Methods and compositions for promoting the neurological development of an infant
US9149452B2 (en) * 2009-04-20 2015-10-06 Women's & Children's Health Research Institute Inc. Methods and compositions for promoting the neurological development of an infant
WO2010134800A1 (en) * 2009-05-19 2010-11-25 N.V. Nutricia Human milk fortifier with high protein and long chain poly unsaturated fatty acids for improving body adipose tissue distribution
KR101889561B1 (ko) * 2009-11-03 2018-08-17 디에스엠 아이피 어셋츠 비.브이. 세포 및 20개 이상의 탄소 원자를 가진 다가불포화 지방산을 포함하는 조성물
WO2011115476A1 (en) * 2010-03-17 2011-09-22 N.V. Nutricia Infant nutrition for improving fatty acid composition of brain membranes later in life
WO2012044155A1 (en) * 2010-09-28 2012-04-05 N.V. Nutricia Fat composition for programming immune response
US9149959B2 (en) 2010-10-22 2015-10-06 Monosol Rx, Llc Manufacturing of small film strips
EP2488042B1 (en) 2010-11-02 2013-10-02 Abbott Laboratories Stable concentrated liquid human milk fortifier
WO2012092087A1 (en) * 2010-12-29 2012-07-05 Abbott Laboratories Methods for decreasing the incidence of necrotizing enterocolitis, colic, and short bowel syndrome in an infant, toddler, or child
SG11201504849WA (en) 2012-12-18 2015-07-30 Abbott Lab Liquid concentrated human milk fortifier containing hypoallergenic protein and lutein
AP2015008623A0 (en) * 2013-02-19 2015-07-31 Tetra Laval Holdings & Finance Process and assembly for recombining a food product
RU2654739C2 (ru) * 2013-04-10 2018-05-22 Нестек С.А. Детская смесь с низким содержанием mcfa в определенных пропорциях и относительно высоким содержанием жирных кислот и ее применение в стимуляции здорового становления когнитивной функции у грудных детей
EP3466277A1 (en) 2013-11-01 2019-04-10 N.V. Nutricia Lipid composition for improving body composition during catch-up growth
US20160296060A1 (en) * 2013-11-22 2016-10-13 Tetra Laval Holdings & Finance S.A. Process and assembly for formulating a food product
AU2014361223B2 (en) 2013-12-12 2018-07-26 Société des Produits Nestlé S.A. Synthetic milk compositions comprising polyunsaturated fatty acids (PUFAs) for promoting the healthy establishment of cognitive function in male and female infant and children
WO2015086170A1 (en) * 2013-12-12 2015-06-18 Nestec S.A. Synthetic milk compositions for optimal growth and development and prevention of obesity in male and female infant and children
EP3848011A1 (en) 2014-05-08 2021-07-14 The Procter & Gamble Company Waist to side silhouettes of adult disposable absorbent articles and arrays
EP3139885B1 (en) 2014-05-08 2021-01-06 The Procter & Gamble Company Arrays of hip to waist silhouettes of adult disposable absorbent articles
JP6367474B2 (ja) 2014-05-08 2018-08-01 ザ プロクター アンド ギャンブル カンパニー 成人用使い捨て吸収性物品の腰部輪郭に対する長さ、及び配列
US10478352B2 (en) 2014-05-08 2019-11-19 The Procter & Gamble Company Length-to-side silhouettes of adult disposable absorbent articles and arrays
CA2947961A1 (en) 2014-05-08 2015-11-12 The Procter & Gamble Company Hip to side silhouettes of adult disposable absorbent articles and arrays
US10034801B2 (en) 2014-10-03 2018-07-31 The Procter & Gamble Company Adult disposable absorbent articles and arrays comprising improved product lengths
EP3204026A1 (en) * 2014-10-08 2017-08-16 Abbott Laboratories Nutritional compositions comprising an oxidizable component and water-soluble plant extract
EP3203957A1 (en) 2014-10-09 2017-08-16 The Procter and Gamble Company Length-to-side and hip-to-waist silhouettes of adult disposable absorbent articles and arrays
US10864117B2 (en) 2014-10-09 2020-12-15 The Procter & Gamble Company Length-to-waist and hip-to-side silhouettes of adult disposable absorbent articles and arrays
EP3223811A1 (en) 2014-11-25 2017-10-04 Abbott Laboratories Method of improving visual processing, visual acuity, or both by administering compositions comprising rrr-alpha-tocopherol and carotenoid to infants
CN107106370B (zh) 2015-01-16 2023-07-18 宝洁公司 包括具有通道的吸收芯的成人一次性吸收制品的系列
JP2016216444A (ja) * 2015-05-20 2016-12-22 国立大学法人広島大学 自然免疫系炎症抑制剤、食品組成物、食品添加物、及び、自然免疫系抑制剤のスクリーニング方法
US10449099B2 (en) 2015-06-25 2019-10-22 The Procter & Gamble Company Adult disposable absorbent articles and arrays of said articles comprising improved capacity profiles
RU2731641C2 (ru) 2015-10-15 2020-09-07 Н.В. Нютрисиа Детская смесь cо специальной структурой липида для стимулирования здорового роста
US10583054B2 (en) 2015-11-06 2020-03-10 The Procter & Gamble Company Disposable absorbent article silhouettes and silhouette arrays
EP3439646B1 (en) * 2016-04-04 2021-06-16 N.V. Nutricia Method for improving language skills in children with suspected or confirmed cerebral palsy or children at increased risk thereof
ES2947592T3 (es) * 2016-04-04 2023-08-11 Nutricia Nv Composición para su uso en la reducción o prevención del retraso global del desarrollo de los niños
BR112018071493A2 (pt) * 2016-04-18 2019-02-19 N.V. Nutricia usos de ácido linoleico (la) e ácido alfa-linolênico (ala) na fabricação de uma composição nutricional, composição nutricional, método para prevenir declínio no funcionamento cognitivo induzido e método para prevenir redução na neurogênese induzida por estresse precoce
KR20230137362A (ko) 2016-05-05 2023-10-04 어퀘스티브 테라퓨틱스, 아이엔씨. 강화된 전달 에프네프린 조성물
US11273131B2 (en) 2016-05-05 2022-03-15 Aquestive Therapeutics, Inc. Pharmaceutical compositions with enhanced permeation
US12433850B2 (en) 2016-05-05 2025-10-07 Aquestive Therapeutics, Inc. Enhanced delivery epinephrine and prodrug compositions
US12427121B2 (en) 2016-05-05 2025-09-30 Aquestive Therapeutics, Inc. Enhanced delivery epinephrine compositions
ES2987545T3 (es) 2016-12-09 2024-11-15 Nutricia Nv Composición nutricional para su uso en la mejora del rendimiento cognitivo y/o la prevención del deterioro cognitivo
WO2018204670A1 (en) 2017-05-04 2018-11-08 The Board Of Trustees Of The Leland Stanford Junior University Neurodevelopment-promoting food compositions and kits, systems and methods related thereto
EP4233989B1 (en) 2017-06-07 2026-01-14 Supira Medical, Inc. Intravascular fluid movement devices, systems, and methods of use
US11432971B2 (en) 2017-06-30 2022-09-06 The Procter & Gamble Company Hip-to-side and waist-to-side silhouettes for bikini/low rise brief type disposable absorbent articles and arrays
CN110799160B (zh) 2017-06-30 2022-05-24 宝洁公司 比基尼/低腰短型一次性吸收制品及系列的长度对侧部轮廓
CN110809459A (zh) 2017-06-30 2020-02-18 宝洁公司 四角紧身内裤/平角内裤型一次性吸收制品和系列的长度对侧部轮廓
EP3644927B1 (en) 2017-06-30 2025-08-27 The Procter & Gamble Company Length-to-hip and length-to-waist silhouettes of disposable absorbent articles
EP3644926B1 (en) 2017-06-30 2025-08-27 The Procter & Gamble Company Hip-to-side silhouettes for boxer brief type disposable absorbent articles
CN111556763B (zh) 2017-11-13 2023-09-01 施菲姆德控股有限责任公司 血管内流体运动装置、系统
CN112004563B (zh) 2018-02-01 2024-08-06 施菲姆德控股有限责任公司 血管内血泵以及使用和制造方法
US12161857B2 (en) 2018-07-31 2024-12-10 Shifamed Holdings, Llc Intravascular blood pumps and methods of use
EP3860675A4 (en) 2018-10-05 2022-07-13 Shifamed Holdings, LLC INTRAVASCULAR BLOOD PUMPS AND METHODS OF USE
EP3996797A4 (en) 2019-07-12 2023-08-02 Shifamed Holdings, LLC INTRAVASCULAR BLOOD PUMPS AND METHOD OF USE AND METHOD OF MAKING
US11654275B2 (en) 2019-07-22 2023-05-23 Shifamed Holdings, Llc Intravascular blood pumps with struts and methods of use and manufacture
EP4010046A4 (en) 2019-08-07 2023-08-30 Calomeni, Michael Catheter blood pumps and collapsible pump housings
US11724089B2 (en) 2019-09-25 2023-08-15 Shifamed Holdings, Llc Intravascular blood pump systems and methods of use and control thereof
WO2021062260A1 (en) 2019-09-25 2021-04-01 Shifamed Holdings, Llc Catheter blood pumps and collapsible blood conduits
WO2021062270A1 (en) 2019-09-25 2021-04-01 Shifamed Holdings, Llc Catheter blood pumps and collapsible pump housings
PH12022551086A1 (en) * 2019-11-08 2024-06-24 Abbott Lab Bovine milk-isolated powdered exosomes, nutritional compositions and methods
EP4072650A4 (en) 2019-12-11 2024-01-10 Shifamed Holdings, LLC Descending aorta and vena cava blood pumps
US12465564B2 (en) 2021-10-25 2025-11-11 Aquestive Therapeutics, Inc. Oral and nasal compositions and methods of treatment

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4670285A (en) 1982-08-06 1987-06-02 The University Of Toronto Innovations Foundation Infant formula
DE3603000A1 (de) 1986-01-31 1987-08-06 Milupa Ag Neue polyensaeure-reiche fettmischung und deren verwendung bei der herstellung von saeuglingsnahrungen
ES2033193B1 (es) * 1990-10-30 1994-01-16 Ganadera Union Ind Agro Mezcla grasa para nutricion infantil y de adultos.
FR2668798B1 (fr) 1990-11-02 1994-10-14 Renault Moteur deux temps.
EP1961312A3 (en) 1991-01-24 2010-03-31 Martek Biosciences Corporation Microbial oil mixture and uses thereof
US5658767A (en) 1991-01-24 1997-08-19 Martek Corporation Arachidonic acid and methods for the production and use thereof
US5223285A (en) 1992-03-31 1993-06-29 Abbott Laboratories Nutritional product for pulmonary patients
FR2721481B1 (fr) 1994-06-27 1996-09-06 Inst Rech Biolog Sa Nouvelles compositions diététiques à base de phospholipides et leur utilisation comme complément nutritionnel.
ATE167983T1 (de) 1994-10-05 1998-07-15 Milupa Gmbh & Co Kg Phospholipidhaltige fettmischung mit lcp- fettsäuren
JP3792309B2 (ja) 1996-08-30 2006-07-05 サントリー株式会社 不飽和脂肪酸含有油脂の製造方法
JP2001516343A (ja) * 1997-02-21 2001-09-25 アボツト・ラボラトリーズ 壊死性全腸炎の発生を減少させるための方法及び組成物
CN1191828C (zh) 1997-03-27 2005-03-09 布里斯托尔-迈尔斯斯奎布公司 二十二碳六烯酸和花生四烯酸促进不足月婴儿生长的用途
SA98190002B1 (ar) 1997-03-28 2006-06-20 ذي يونيفيرسيتي اوف تننيسي ريسيرش كوربوريشن استخدام أحماض دهنية تحتوي على عدة روابط غير مشبعة polyunsaturated fatty acids لتقليل حدوث الالتهاب المعوي القولوني الناخر incidence of necrotizing enterocolitis
US6297279B1 (en) * 1997-07-22 2001-10-02 Nestac S.A. Lipid composition for infant formula and method of preparation
US6294206B1 (en) * 1999-04-09 2001-09-25 Abbott Laboratories Powdered human milk fortifier
US6495599B2 (en) * 2000-04-13 2002-12-17 Abbott Laboratories Infant formulas containing long-chain polyunsaturated fatty acids and uses therof

Also Published As

Publication number Publication date
SA02220638B1 (ar) 2008-01-30
CN1436048A (zh) 2003-08-13
EP1272058A2 (en) 2003-01-08
JP2004518609A (ja) 2004-06-24
BR0107069A (pt) 2006-02-07
US6495599B2 (en) 2002-12-17
DK1272058T3 (en) 2015-09-21
CA2405822A1 (en) 2001-10-25
IL151970A0 (en) 2003-04-10
KR20020090232A (ko) 2002-11-30
KR100793048B1 (ko) 2008-01-10
US20020004527A1 (en) 2002-01-10
CA2405822C (en) 2007-12-11
AU2001255337A8 (en) 2005-09-08
US20020045660A1 (en) 2002-04-18
WO2001078530A3 (en) 2002-08-01
MXPA02010085A (es) 2003-10-15
US6596302B2 (en) 2003-07-22
US20030190363A1 (en) 2003-10-09
WO2001078530A2 (en) 2001-10-25
IL151970A (en) 2006-10-31
EP1272058B1 (en) 2015-06-24
AU2001255337A1 (en) 2001-10-30
JP2012144535A (ja) 2012-08-02
ES2544853T3 (es) 2015-09-04
HK1053247A1 (en) 2003-10-17

Similar Documents

Publication Publication Date Title
AR028331A1 (es) Formula para bebes que contiene acidos grasos poli-insaturados de cadena larga y sus usos
DK1385498T3 (da) Fedtsyrer som overlevelses- og aktiveringsfaktorer for neutrofiler
EE200300030A (et) 4-jodofenüülaminobenshüdroksaamhapete oksügeenitud estrid
NO20020090L (no) Farmasöytiske og n¶ringsformuleringer inneholdende essensielle fettsyrer og homocystein-senkende midler
IS6709A (is) Fljótandi samsetningar metformíns
GB0016452D0 (en) Vitamin K and essential fatty acids
EP1297598A4 (en) POWER SUPPLY
ATE353882T1 (de) Heteroarylalkyl piperazinederivate als partielle inhibitoren der fettsäureoxidation
CL2004001594A1 (es) FORMULA DE LECHE SINTETICA PARA LACTANTES, QUE COMPRENDE 35 A 560 mg/dl DE ACIDOS GRASOS POLIINSATURADOS DE CADENA LARGA, 200 A 2300 mg/l DE ACIDOS SIALICOS Y 10 A 40 mg/dl DE COLESTEROL.
DE60135392D1 (de) Verpacktes Nahrungsmittelprodukt
EP1294378A4 (en) Thrombopoietin mimetics
DZ3268A1 (fr) Synthese asymetrique de pregabaline
AR027924A1 (es) Formulacion y sus usos
DK1267899T3 (da) ssa-inaktiverede salmonellavacciner
DE50108902D1 (de) Wässrige überzugsmittel für festkörperreiche einbrennlackierungen
DE50005268D1 (de) Verzweigte weitgehend ungesättigte fettalkoholsulfate
AR028310A1 (es) Dispositivo dosificador para productos fluidos
ATE291422T1 (de) Inierzierbare valnemulin formulierung
PT1263421E (pt) Avasimibe, o inibidor duplo da sintese de ester de colesterilo e de ester ceroso, para o tratamento de disturbios da glandula sebacea
AR028425A1 (es) Diseno de porcion de alimento rapido que tiene densidad empacada aumentada
MA28949B1 (fr) Alcools gras de longueur de chaine moyenne en tant que stimulateurs de l'hematopoiese
NO20030629D0 (no) Mattilsetning
DE60141321D1 (de) Geräuscharmer Transformator
DE50113518D1 (de) Interlabialer hygieneartikel
AR028007A1 (es) Procedimiento para preparar eteres de oxima

Legal Events

Date Code Title Description
FB Suspension of granting procedure